Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference

Xanadu and EV Group partner to build industrial-scale photonic quantum hardware

Marriott Vacations Worldwide Reports First Quarter 2026 Financial Results

Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Shopify Delivers Again as Merchants Clear $100 Billion in Q1 GMV

UL Solutions Inc. Reports Strong First Quarter 2026 Results

Domo Appoints Ben Schein as Chief AI and Analytics Officer

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia

Bowhead Specialty Holdings Inc. Reports First Quarter 2026 Results

Generac Urges Consumers Not to Overlook Hurricane Season Readiness

Rockwell Automation Reports Second Quarter 2026 Results

KKR & Co. Inc. Reports First Quarter 2026 Results

BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

Pentair Pool and Pool Brain to Release Technology Integration to Accelerate Digital Transformation of Pool Service Through Data-Driven Insights

Energizer Holdings, Inc. Announces Fiscal 2026 Second Quarter Results

Target Hospitality Announces First Quarter 2026 Earnings Release and Conference Call Schedule

Aptiv Reports First Quarter 2026 Financial Results

TopBuild Reports First Quarter 2026 Results

Life Time Reports First Quarter 2026 Financial Results

Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years